Bruce C. Cozadd

2016

In 2016, Bruce C. Cozadd earned a total compensation of $8.8M as Chairman and CEO at Jazz Pharmaceuticals, a 18% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$914,600
Option Awards$3,109,285
Salary$917,308
Stock Awards$3,824,157
Other$5,622
Total$8,770,972

Cozadd received $3.8M in stock awards, accounting for 44% of the total pay in 2016.

Cozadd also received $914.6K in non-equity incentive plan, $3.1M in option awards, $917.3K in salary and $5.6K in other compensation.

Rankings

In 2016, Bruce C. Cozadd's compensation ranked 652nd out of 14,075 executives tracked by ExecPay. In other words, Cozadd earned more than 95.4% of executives.

ClassificationRankingPercentile
All
652
out of 14,075
95th
Division
Manufacturing
214
out of 5,489
96th
Major group
Chemicals And Allied Products
51
out of 1,895
97th
Industry group
Drugs
33
out of 1,538
98th
Industry
Pharmaceutical Preparations
25
out of 1,176
98th
Source: SEC filing on June 20, 2017.

Cozadd's colleagues

We found five more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2016.

2016

Russell Cox

Jazz Pharmaceuticals

Chief Operating Officer

2016

Suzanne Hooper

Jazz Pharmaceuticals

Executive Vice President and GC

2016

Matthew Young

Jazz Pharmaceuticals

Chief Financial Officer

2016

Karen Smith

Jazz Pharmaceuticals

Chief Marketing Officer

2016

Michael Miller

Jazz Pharmaceuticals

Executive Vice President U.S Commercial

News

You may also like